Pt(II) vs Pd(II) Polyamine Complexes as New Anticancer Drugs: A Structure- Activity Study

E-ISSN： 1875-628x|3|3|149-151

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.3, 2006-04, pp. : 149-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis, physicochemical investigation and cytotoxic activity of new Pt(II) complexes with hydantoin ligands

By Bakalova A. Buyukliev R. Tcholakova I. Momekov G. Konstantinov S. Karaivanova M.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 6, 2003-06 ,pp. : 627-632

Elsevier

Access to resources Recommend Favorite

Monofunctional Platinum (PtII) Compounds – Shifting the Paradigm in Designing New Pt-based Anticancer Agents

Current Medicinal Chemistry, Vol. 23, Iss. 12, 2016-05 ,pp. : 1268-1285

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Interaction Fields (MIFs) to Predict Lipophilicity and ADME Profile of Antitumor Pt(II) Complexes

By Caron Giulia Ravera Mauro Ermondi Giuseppe

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 640-646

Springer Publishing Company

Access to resources Recommend Favorite

Dual Topoisomerase I/II Poisons as Anticancer Drugs

By Denny W.A.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1845-1852

Informa Healthcare

Access to resources Recommend Favorite

Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 10, 2016-07 ,pp. : 804-814

Bentham Science Publishers

Access to resources Recommend Favorite